Main menu

In Science Translational Medicine this week, two researchers from the Massachusetts Institute of Technology call for greater focus on improving collaborations between different stakeholders in biomedical innovation in an effort to combat "consortium fatigue." Although there is a growing interest in initiatives between various pharmaceutical and academic entities, "little research has been conducted to assess the effectiveness of these alliances or to identify successful characteristics that can be applied